Table 1.
Vector | Type of virus | Cargo capacity (kb) | Predominant immune response | Clinical development stage |
---|---|---|---|---|
Cytomegalovirus | DNA | >6 | CD4+, CD8+ and antibodies | Phase I |
Novel adenoviruses | DNA | 7 | CD8+ and antibodies | Phase II |
Vesicular stomatitis virus | ‐ssRNA | 6 | Antibodies and some CD4+, CD8+ | Phase III |
Measles virus | ‐ssRNA | >6 | CD4+ and antibodies | Phase I |